Survival of dental implants placed in HIV-positive patients: a systematic review
Carregando...
Data
2018-10-01
Autores
Lemos, C. A.A. [UNESP]
Verri, F. R. [UNESP]
Cruz, R. S. [UNESP]
Santiago Júnior, J. F.
Faverani, L. P. [UNESP]
Pellizzer, E. P. [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
No consensus has been reached on the use of dental implants in human immunodeficiency virus (HIV)-positive patients. This systematic review evaluated dental implants in HIV-positive patients in terms of implant survival and success rates, marginal bone loss, and complications. The review was conducted according to the PRISMA checklist. Two independent reviewers performed a comprehensive search of the PubMed/MEDLINE, Scopus, and Cochrane Library databases for studies published until October 2017. Six studies were selected for review. In total, 821 implants were placed: 493 in 169 HIV-positive patients, and 328 in 135 HIV-negative patients. The mean duration of follow-up was 47.9 months. Weighted mean survival rate, success rate, and marginal bone loss values were calculated for the HIV-positive patients. Mean survival and success rates at the patient level (according to the number of patients) were 94.76% and 93.81%, respectively; when calculated at the implant level (according to the number of implants), these rates were 94.53% and 90.37%, respectively. Mean marginal bone loss was 0.83 mm at the patient level and 0.99 mm at the implant level. Thus, dental implants are suitable for the rehabilitation of HIV-positive patients with controlled risk factors and normal CD4+ cell counts.
Descrição
Palavras-chave
complications, dental implant, human immunodeficiency virus, marginal bone loss, success, systematic review
Como citar
International Journal of Oral and Maxillofacial Surgery, v. 47, n. 10, p. 1336-1342, 2018.